Reactive Astrocytes Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۱-۱۵ از ۲۰۰ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Anna G Orrمشاهده پروفایل

استادیار

Cornell UniversityUnited States

Anna G Orr serves as Nan and Stephen Swid Assistant Professor of Frontotemporal Dementia Research and Assistant Professor of Neuroscience at Weill Cornell Medical College's Brain and Mind Research Institute since 2016, leading pioneering research on astrocyte biology in dementia pathogenesis. Her educational background includes: Ph.D. from Emory University (2008) B.S. from Allegheny College (2002) Dr. Orr's research program centers on astrocytic-neuronal interactions , mitochondrial signaling , and neuroimmune mechanisms through three interconnected pathways: neuroimmune , oxidative , and G protein-coupled signaling . Her lab investigates how these mechanisms influence neuroinflammation, protein aggregation, synaptic function, and behavioral outcomes in dementia, with parallel therapeutic discovery efforts targeting astrocytic pathways for novel dementia treatments. Analysis of her 15 most recent publications (2025-2010) reveals escalating focus on astrocyte-specific dementia mechanisms , particularly mitochondrial ROS signaling, sex-dimorphic memory effects, TDP-43 pathology interactions with antiviral pathways, and lipid dysregulation in neurodegeneration. Her work consistently bridges molecular discoveries with therapeutic applications, demonstrating increasing NIH funding support for translational approaches. Key scientific recognitions include: NIH K99/R00 Pathway to Independence Award (2017) Leon Levy Fellowship in Neuroscience (2021) Nan and Stephen Swid Endowed Professorship (2021) Outstanding Neuroscience Teaching Award (2021) Dr. Orr actively mentors eight trainees across career stages, including Ph.D. candidates Evelyn Hardin and Constance Zhou, while securing major NIH grants as Principal Investigator for projects like Uncovering Dementia-Related Lipid Alterations in Astrocytes (NIA 2024-2026) and Mitochondrial Complex III Free Radicals in Dementia Pathology (NIA 2020-2026), alongside collaborative awards from the Alzheimer's Association. Her Orr Lab maintains a dual focus on mechanistic astrocyte biology and therapeutic translation, with current projects examining astrocytic TDP-43 dysregulation, mitochondrial complex III signaling, and sex-specific memory mechanisms using advanced in vivo techniques and disease models.

پروفایل رسمی دانشگاه

Cam Ha Tranمشاهده پروفایل

استادیار

University of Nevada, RenoUnited States

Cam Ha Tran is an Assistant Professor in the Department of Physiology and Cell Biology at the University of Nevada, Reno, affiliated with the Institute of Neuroscience. Her research focuses on neurovascular unit interactions, particularly how blood flow regulation impacts brain function under health and disease conditions such as stroke and dementia. She employs advanced techniques like two-photon imaging, optogenetics, and electrophysiology to study astrocyte-endothelial communication and vascular reactivity. Education: PhD in Cardiovascular and Respiratory Sciences from the Cumming School of Medicine, University of Calgary (Canada); Master of Biomedical Technology and Bachelor of Science from the University of Alberta (Canada). Research emphasizes understanding how astrocytes and endothelial cells coordinate to maintain cerebral blood flow, with implications for neurological disorders. Her recent work explores TRPA1 channels in neurovascular coupling, astrocyte dysfunction in Alzheimer’s, and seizure-induced vascular changes. Techniques include in vivo imaging and chemogenetic approaches to dissect cellular mechanisms. Key contributions include uncovering astrocyte roles in functional hyperemia and identifying therapeutic targets for cerebrovascular diseases. Her lab’s findings bridge basic science and clinical applications, aiming to improve diagnostics and treatments for stroke and neurodegenerative conditions.

پروفایل رسمی دانشگاه

Laura Fonkenمشاهده پروفایل

دانشیار

University of Texas at AustinUnited States

Laura Fonken, Ph.D. is an Associate Professor of Pharmacology & Toxicology at the University of Texas at Austin's College of Pharmacy. She holds the prestigious Lonnie F. Hollingsworth, Sr. Centennial Fellowship in Pharmacy and leads an active research laboratory focused on neuroimmunology. Dr. Fonken's research broadly investigates how interactions among the immune, nervous, and endocrine systems regulate complex behavioral processes such as cognitive and mood-related behaviors. Her lab particularly focuses on two main research directions: (1) Targeting neuroinflammatory responses in the aged brain to improve cognitive function, and (2) Understanding the mechanisms by which the circadian system regulates neuroimmune function across the lifespan. Her work centers on microglia, the brain's resident immune cells, and how they shape behavior across the lifespan through endogenous factors like circadian rhythms and aging, as well as exogenous factors such as environmental pollutants, infection, and injury. Her research has identified that microglia become more reactive or 'primed' over an animal's lifespan, worsening outcomes when immune challenges are encountered. Her lab is investigating mechanisms by which Mycobacterium vaccae vaccination prevents exacerbated neuroinflammatory and behavioral deficits in aging, supported by NIH R01 AG062716. She is also examining how circadian rhythms in immune cell trafficking become disrupted with age and Alzheimer's Disease-like pathology, supported by NIH R01 AG078758. Dr. Fonken's publications reveal a strong focus on neuroimmunology, circadian biology, and aging. Her work demonstrates significant contributions to understanding sex differences in microglial function, the impact of hormonal changes on neuroinflammation, and the therapeutic potential of immunomodulation for age-related cognitive decline. Lonnie F. Hollingsworth, Sr. Centennial Fellowship in Pharmacy NIH R01 AG062716 grant NIH R01 AG078758 grant Dr. Fonken actively mentors graduate students across multiple programs, including Pharmaceutical Sciences (Division of Pharmacology & Toxicology) and Neuroscience (Institute for Neuroscience). Her lab has successfully graduated two PhD students (Dr. Kevin Sanchez and Dr. Rachel Chen in 2023) and currently mentors several graduate students including Kate Davis, Brandy Routh, Kiersten Bell, Drew Hynes, and Kate Callahan. She has successfully guided her students to win numerous prestigious awards including the CCST Science & Technology Policy Fellowship, NIH predoctoral fellowships, and national competition wins. The Fonken Lab maintains an active research presence with collaborations across disciplines and participation in major conferences including the Society for Neuroscience and the International Behavioral Neuroscience Society.

پروفایل رسمی دانشگاه

Zahoor Shahمشاهده پروفایل

استاد

University of ToledoUnited States

Zahoor Shah, Ph.D. , is a Professor and Vice Chair in the Department of Medicinal and Biological Chemistry at the College of Pharmacy and Pharmaceutical Sciences , The University of Toledo . He serves as Associate Dean for Graduate Education and Research and Program Director . Dr. Shah obtained his doctorate in Toxicology from Hamdard University (New Delhi, India) and completed postdoctoral training at the University of Louisville (2005) and Johns Hopkins University (2007). 2005: Postdoctoral Fellow, University of Louisville 2007: Postdoctoral Fellow, Johns Hopkins University 2009: Instructor, Johns Hopkins University Dr. Shah’s research focuses on identifying molecular targets and developing drugs for ischemic and hemorrhagic brain injuries . Key areas include: Neuroprotective agents targeting oxidative stress and inflammation Role of Nrf2/HO1 pathway in stroke recovery Mechanistic studies of cofilin signaling in neuroinflammation Preclinical models of stroke (t-MCAO, pMCAO, BCCAO) and zebrafish Alzheimer’s models Development of ROS-sensitive nitric oxide synthase inhibitors Patents in oxidative stress-related therapies His 15 most recent articles (2022–2024) emphasize: Therapeutic targeting of cofilin and neuroinflammation in stroke and neurodegenerative diseases Interplay between gut microbiota and cognitive decline Preclinical validation of anti-inflammatory agents (e.g., triazole-pyrimidine hybrids) Impact of metabolic factors (diabetes, hyperglycemia) on brain injury outcomes Dr. Shah has received major grants including NINDS R01 (2020–2025) and NIA R01 (2018–2023), and holds patents for neuroprotective compositions (US Patent 10,590,119; provisional applications D2018-11 and D2019-35). He has published over 83 peer-reviewed articles and mentored numerous graduate and undergraduate students.

پروفایل رسمی دانشگاه

Bianca Papottiمشاهده پروفایل

پژوهشگر

University of ParmaItaly

Bianca Papotti is a fixed-term Researcher at the Department of Food and Pharmaceutical Sciences, University of Parma. Her academic career spans interdisciplinary research in Pharmacology Cholesterol Metabolism Neurodegenerative Diseases Cardiovascular Pathology Immunometabolism . She teaches courses including Experimental Pharmacology and Food Toxicology. Her research focuses on the role of PCSK9 and cholesterol efflux in Alzheimer's Disease Atherosclerosis Rheumatoid Arthritis Lipoprotein Biology Inflammatory Disease Drug Development . Key trends in her publications (3 in 2025, 12 in 2024) reveal strong emphasis on PCSK9 inhibition mechanisms, cholesterol-immune crosstalk in rheumatoid arthritis, and fasting interventions in lipid-related pathologies. Her work has explored PCSK9's neuroinflammatory effects ABCA1/ABCG1 transporter dynamics Macrophage cholesterol loading Natural compound screening HDL dysfunction in diabetes Covid-19 lipid interactions .

پروفایل رسمی دانشگاه

Ole Petter Ottersenمشاهده پروفایل

استاد

University of OsloNorway

Ole Petter Ottersen is a Professor at the University of Oslo’s Faculty of Medicine, affiliated with the Institute of Basic Medical Sciences. He previously served as Rector of the University of Oslo (2009–2017) and President of Karolinska Institutet (2017–2023). Ottersen holds dual roles as a Visiting Professor at Charité – Universitätsmedizin Berlin’s Global Health Institute and an affiliated member of Karolinska’s Department of Neuroscience and Department of Global Public Health. He is also Vice President of the Virchow Foundation and chairs the Lancet Commission on Global Governance for Health 2.0. His career spans academic leadership, research coordination, and international health policy advocacy. Education: He earned an M.D. (1980) and Ph.D. in Neuroscience (1982) from the University of Oslo. Ottersen has held academic positions including Research Fellow (1978–1983), Associate Professor (1983–1992), and has coordinated prestigious EU and Nordic grants. His research priorities include academic quality, internationalization, innovation, and dissemination. Research interests focus on molecular neuroscience (e.g., aquaporin-4 channels in brain water dynamics) and global health governance. His work bridges basic science and policy, addressing health inequity, pandemic preparedness, and sustainable healthcare. Recent publications emphasize systemic approaches to global crises, vaccine equity, and interdisciplinary solutions for health challenges. Ottersen has received the Anders Jahre Medical Prize (twice), the Lundbeck Nordic Research Prize, and honorary doctorates from multiple institutions. His awards include France’s Ordre national du Mérite (2019) and Japan’s Order of the Rising Sun (2023). He has led prize committees, including the Kavli Prize in Neuroscience. He has coordinated major national and international grants, such as Norway’s Functional Genomics Program (FUGE) and the EU’s Biomed and NeuroImage projects. His advisory roles include the European Research Council (ERC), WHO-related initiatives, and boards like Oslo University Hospital and NordForsk. Ottersen’s teaching spans medical students since 1976, covering neurobiology, histology, and anatomy. Key initiatives include founding the Guild of European Research-Intensive Universities and leading the Lancet Commission on Global Governance for Health. He collaborates with institutions like EMBL-Norway, Africa CDC, and the Global Virus Network, emphasizing intersectoral action and equitable global health systems.

پروفایل رسمی دانشگاه

Ukpong Eyoمشاهده پروفایل

استادیار

University of VirginiaUnited States

Ukpong Eyo, Ph.D., is an Assistant Professor in the Department of Neuroscience at the University of Virginia School of Medicine and Principal Investigator of the MicroglEyo Lab. His lab is affiliated with the Center for Brain Immunology and Glia (BIG), focusing on microglial roles in neurodevelopment and neurodevelopmental pathologies. He leads a dynamic research team including postdoctoral fellows, graduate and undergraduate students. BS, Biology: Pre-Professional Zoology, Northwest Missouri State PhD, Biology: Neuroscience, University of Iowa Postdoc, Microglia-Neuron Interactions, Rutgers University, NJ Postdoc, Microglia-Neuron Interactions, Mayo Clinic, Rochester, MN Dr. Eyo's research centers on neuroimmunology, particularly microglia in brain development and disease. His work investigates microglia-neuron interactions , microglial maturation , reactivity in injury , and behavioral impacts in neurodevelopmental disorders . He employs advanced imaging techniques to study real-time microglial dynamics. The recent publications highlight a consistent focus on microglial process dynamics regulated by purinergic and glutamatergic signaling, especially through P2Y12 and NMDA receptors. Themes include microglial responses to seizures, calcium modulation, and fractalkine signaling in neuroimmune crosstalk. Dr. Eyo has not been mentioned with any scientific awards in the provided text. He mentors several trainees, including graduate students Joseph Uweru and Synphane Gibbs, and multiple undergraduates. His lab receives institutional support through affiliations with the BIG Center and UVA’s Neuroscience Department. No external grants are detailed, but his T32 fellowship involvement with Tré Mills suggests participation in funded training programs. The Eyo Lab, also known as the MicroglEyo Lab, is an active research group within UVA’s neuroscience community, focusing on glial biology and neuroimmune mechanisms. Lab members include postdoctoral researchers like Kanchan Bisht, Kaushik Sharma, and Tré Mills, working on microglia-vasculature and astrocyte-microglia interactions.

پروفایل رسمی دانشگاه

Steven Petratosمشاهده پروفایل

مدرس ارشد

Monash UniversityAustralia

Dr. Steven Petratos is a Senior Lecturer in Pathology within the Department of Medicine at Monash University's School of Translational Medicine, Australia. He is also a Senior Research Fellow and leads an active research group focused on neurodegeneration in Multiple Sclerosis. His work is affiliated with the Alfred Hospital, and he holds a Visiting Professorship at Aristotle University of Thessaloniki, Greece. PhD in Neuropathology, University of Melbourne (1993–1999) Steven Petratos is a neurobiologist whose research centers on the molecular mechanisms governing neurodegeneration in Multiple Sclerosis (MS). His work spans neurorepair, remyelination, stem cell therapies, Nogo signaling, oligodendrocyte biology, and thyroid hormone pathways . He investigates how inhibitory signals like Nogo-A contribute to axonal damage and how these can be therapeutically targeted. His lab explores both small molecule interventions and cell-based delivery systems, such as genetically modified haematopoietic stem cells, to promote CNS repair. His research has significant implications for progressive MS and drug repurposing. His recent publications (2023–2024) reflect a strong focus on mitochondrial dysfunction in oligodendrocytes, microglial and astrocyte activation in MS lesions, Nogo receptor modulation, and stem cell-mediated neurorepair . He frequently publishes in high-impact journals such as Brain Communications , Neuroscience and Biobehavioral Reviews , and Frontiers in Cellular Neuroscience , demonstrating consistent contributions to understanding MS pathogenesis and therapy development. Scientific Awards: Commonwealth AIDS Research Grants (CARG) Postgraduate Scholarship (1993–1996) Monash University, Faculty of Medicine, Post-Doctoral Fellowship (2004) Monash University, Faculty of Medicine, Senior Post-Doctoral Fellowship (2005) Dr. Petratos actively supervises PhD students and early-career researchers, fostering a collaborative environment. He is the Primary Chief Investigator on multiple funded projects from organizations like the Trish MS Research Foundation and the 1More Foundation, focusing on preclinical development of therapies for MS. His lab, the Petratos Group, is part of the Centre for Neuroscience at Monash and works on translational research aimed at bridging laboratory findings to clinical applications. He contributes to UN Sustainable Development Goals related to health and well-being through his work on neurological disorders.

پروفایل رسمی دانشگاه

Yusuke Toyamaمشاهده پروفایل

دانشیار

National University of SingaporeSingapore

Yusuke Toyama is an Associate Professor at the National University of Singapore (NUS) in the Department of Biological Sciences (Faculty of Science) and a Principal Investigator at the Mechanobiology Institute (MBI). His high-impact research earned him the Dean's Chair in the Faculty of Science in 2018. Education: PhD in Engineering, Osaka University, Japan (2003) Undergraduate studies, Hokkaido University, Japan Dr. Toyama investigates tissue mechanics and homeostasis, focusing on apoptotic cell extrusion from epithelial tissues. His lab discovered that actomyosin-driven cytoskeletal rearrangements in neighboring cells mechanically expel dying cells. Recent work reveals immune cells also provide critical mechanical force for apoptotic clearance. His interdisciplinary approach integrates super-resolution imaging, optogenetics, biophysical force measurements, and machine learning to decipher tissue dynamics. His 2021-2025 publications demonstrate consistent focus on epithelial mechanics, neural stem cell reactivation, and cell junction dynamics. Key themes include F-actin's role in tissue integrity, force transmission at adherens junctions, and immune cell mechanics in homeostasis. Studies frequently employ Drosophila and mammalian models with advanced biophysical techniques to uncover conserved tissue organization principles. Scientific Awards: Dean's Chair in the Faculty of Science, NUS (2018) Dr. Toyama mentors six PhD students including Le Thuy Truc Anh (2024) and Vinod S/O Prabhakaran (2023). His research is funded by NUS and MBI, supporting investigations into tissue mechanobiology and apoptotic clearance mechanisms through interdisciplinary collaborations. He leads the Mechanotransduction in Tissues Group at MBI, collaborating with the Ladoux Lab (cell adhesion), Kanchanawong Lab (super-resolution imaging), and Ravasio Lab (tissue mechanics). His team integrates physicists, biologists, and engineers to study mechanical regulation of tissue organization.

پروفایل رسمی دانشگاه

Eugenia Trushinaمشاهده پروفایل

استاد

Mayo Clinic College of Medicine and ScienceUnited States

Eugenia Trushina, Ph.D., is a Professor of Neurology and Pharmacology at Mayo Clinic in Rochester, Minnesota, where she serves as a Consultant in the Department of Neurology and the Department of Molecular Pharmacology and Experimental Therapeutics. Her research is centered on mitochondrial dysfunction in neurodegenerative diseases such as Alzheimer's and Huntington's disease, aging, and chemotherapy-induced neuropathy. Ph.D. in Chemistry, Saratov State University Postdoctoral Fellowship, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Dr. Trushina’s research focuses on the molecular mechanisms of mitochondrial dynamics and function in neurons, particularly how environmental toxins, genetic factors, and chemotherapy drugs contribute to neurodegeneration. Her lab is developing biomarkers for early detection of mitochondrial dysfunction and testing mitochondria-targeted therapeutics to reverse neurodegeneration. Recent work emphasizes mitochondrial complex I inhibition, metabolomics in inclusion body myositis, and neuroprotective small molecules in Alzheimer’s models. Her publication and grant activity show a strong trend in targeting mitochondrial pathways—such as mitophagy, oxidative stress, and metabolic dysregulation—for therapeutic intervention in neurodegenerative and age-related disorders. This includes both preclinical models and translational biomarker development. Dr. Trushina’s research has been funded by: National Institute on Aging (NIA) National Institute of Neurological Disorders and Stroke (NINDS) Mayo Clinic Alzheimer's Disease Research Center Alzheimer Drug Discovery Foundation American Health Assistance Foundation She has served as Principal Investigator (PI) and Co-PI on multiple NIH grants, including ongoing projects on mitochondrial complex I as a neuroprotective target and the role of chronic alcohol exposure in Alzheimer’s pathophysiology. She mentors junior researchers and collaborates across disciplines, though specific student names are not listed. Her work is conducted within the Mitochondrial Neurobiology and Therapeutics research group at Mayo Clinic.

پروفایل رسمی دانشگاه

Kounosuke Watabeمشاهده پروفایل

استاد

Wake Forest UniversityUnited States

Kounosuke Watabe is a Professor in the Department of Cancer Biology at Wake Forest University School of Medicine. He serves as Associate Director of Education and Training and Shared Resources at the Wake Forest Baptist Comprehensive Cancer Center. Research focus on tumor microenvironment, cancer stem cells, and non-coding RNAs in breast and prostate cancers Published over 150 papers with an h-index of 51 Director of T32 Translational Oncology Training Program and R25 cancer research promotion program Research Interests: The lab investigates molecular mechanisms of tumor metastasis, particularly in breast and prostate cancers. Key areas include: Tumor microenvironment interactions in bone and brain metastasis Non-coding RNA regulation of cancer progression Fatty acid metabolism in tumor initiation Cancer stem cell dynamics Development of immunotherapies to control metastasis Scientific Awards: Molecule of the Year (2011) by ISMCBBPR Top 100 Science Discovery (2013) in Discover Magazine Research Trends: Recent publications emphasize exosomal miRNAs (2021), nicotine's role in metastasis (2021), and multi-omics analysis of brain metastasis outcomes (2020). Earlier work established fatty acid synthase as a therapeutic target (2005-2008) and clarified microRNA regulation of cancer stem cells (2009-2013). Leadership & Funding: He has served on federal grant review panels and led team science projects across three institutions. His research has received continuous NIH and federal funding. Labs & Collaborations: The Kounosuke Watabe Lab collaborates with Wake Forest Institute for Regenerative Medicine (WFIRM), Maya Angelou Research Center for Healthy Communities, and Public Health Sciences departments.

پروفایل رسمی دانشگاه

Henrik Ahleniusمشاهده پروفایل

مدرس ارشد

Lund UniversitySweden

Henrik Ahlenius is a Senior Lecturer and Research Team Manager at Lund University's Faculty of Medicine, Department of Experimental Medical Science. He serves as Principal Investigator for multiple prestigious research initiatives including StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, LUCC: Lund University Cancer Centre, and MultiPark: Multidisciplinary research focused on Parkinson's disease. His research focuses on understanding how aging and neurodegenerative diseases affect the brain, neural cells and neural stem cells. His laboratory utilizes cutting-edge stem cell, reprogramming and genome editing technologies to investigate genetic pathways involved in aging and neurodegenerative disease. Key research areas include developing cellular models of human neuronal aging and degeneration, investigating mechanisms of dysfunction in neurons and neural stem cells in the aging and diseased brain, and studying regulation of normal neurogenesis. Analysis of his recent publications reveals a strong focus on stem cell models of neurodegenerative diseases, neural differentiation, aging brain mechanisms, and cellular reprogramming approaches. His work spans multiple neurological conditions including Alexander disease, Parkinson's disease, glioblastoma, and general mechanisms of brain aging. Senior Lecturer, Research Team Manager Principal Investigator, StemTherapy Principal Investigator, LUCC Principal Investigator, MultiPark Dr. Ahlenius actively supervises PhD students and has organized major scientific events including UniStem Day 2024. His research has significant implications for understanding and treating neurodegenerative conditions and contributes to UN Sustainable Development Goals related to health and well-being.

پروفایل رسمی دانشگاه

Gordon Rintoulمشاهده پروفایل

دانشیار

Simon Fraser UniversityCanada

Gordon Rintoul is an Associate Professor in the Department of Biological Sciences at Simon Fraser University (SFU). His primary focus is on mitochondrial dynamics and their role in neurodegenerative diseases such as Parkinson's and Huntington's. He leads the Rintoul Lab, which investigates how mitochondrial movement, morphology, and function impact neuronal health and injury mechanisms. Rintoul holds a BSc from the University of Western Ontario and a PhD from the University of British Columbia. His research explores mitochondrial trafficking, fission/fusion processes, and their modulation by calcium, ROS, and neurotoxins. Key themes include understanding how mitochondrial dysfunction contributes to neurodegeneration and neuronal injury. He teaches courses like BISC 305 (Animal Physiology) and BISC 405 (Neurobiology), emphasizing cellular and molecular neuroscience principles. Rintoul's work has been supported by grants from organizations like the Canadian Institutes of Health Research (CIHR). He mentors undergraduate and graduate students in techniques including cell culture, molecular biology, and fluorescence microscopy. His lab collaborates on projects involving mitochondrial dynamics in trans-differentiated fibroblasts and neurodegenerative disease models. Publications highlight discoveries in mitochondrial remodelling, kinesin motor protein roles, and zinc-induced trafficking impairments. While no explicit awards are listed, his contributions to neurobiology are recognized through sustained academic activity and grant funding.

پروفایل رسمی دانشگاه

Jin Mo Chungمشاهده پروفایل

استاد

The University of Texas Medical Branch at GalvestonUnited States

Jin Mo Chung is a Professor and Chair at the University of Texas Medical Branch (UTMB), holding the Cecil H. and Ida M. Green Distinguished University Endowed Chair in Neuroscience and Cell Biology. His work focuses on chronic pain mechanisms, particularly neuropathic pain, where he developed the foundational 'spinal nerve ligation (SNL) Chung Model' for testing analgesics. With over 160 peer-reviewed publications and 23,000 citations, his research has been NIH-funded for 35 years, including multiple R01 and Program Project Grants. Education: BS in Physics, Sogang University PhD in Physiology, Loyola-Stritch School of Medicine Post-Doctoral in Neurophysiology, Loyola-Stritch Post-Doctoral in Somatosensory Neurophysiology, UTMB Chung's research spans synaptic plasticity in pain pathways, reactive oxygen species (ROS) in chronic pain, and treatment strategies for conditions like spinal cord injury, diabetic neuropathy, HIV infection, and chemotherapy-induced pain. He has pioneered animal models for pain research and explored interventions like spinal cord stimulation, antioxidant therapy, and electroacupuncture. The 15 most recent articles reflect a focus on pain neurobiology, ROS signaling, neuroinflammation, and neuromodulation techniques. Key subfields include FGF13 in diabetic neuropathy, Wnt5a signaling in HIV-related pain, opioid-induced hyperalgesia, circadian regulation of chemotherapy pain, and neuron-type-specific spinal cord stimulation. Scientific Contributions: Developed the 'Chung Model' of spinal nerve ligation Over 160 peer-reviewed publications NIH R01 and Program Project Grants (35 years) Co-editor of Encyclopedia of Pain Chung has mentored 30 postdoctoral fellows and 22 visiting scientists. He co-founded the Association of Korean Neuroscientists and led the Gulf Coast Consortium and Texas Pain Research Consortium. His work connects basic science to clinical applications, with global impacts on analgesic drug development.

پروفایل رسمی دانشگاه

Denise R. Garciaمشاهده پروفایل

دانشیار

Drexel UniversityUnited States

A. Denise R. Garcia, PhD is an Associate Professor in the Department of Neurobiology & Anatomy at Drexel University College of Medicine. Her research focuses on astrocyte biology and their roles in neural circuit assembly during brain development, particularly through Sonic Hedgehog signaling pathways. PhD in Neurobiology, University of California, Los Angeles BS in Biology with Neuroscience specialization, University of California, Irvine Research Interests: Neurodevelopmental processes Astrocyte-neuron interactions Sonic Hedgehog signaling in glia Astrocyte heterogeneity and functional diversity Synaptic organization and repair Publication Trends: Analysis of her 15 most recent articles reveals consistent focus on astrocyte biology, Sonic Hedgehog signaling, and neural circuit development. Work spans molecular neuroscience, developmental biology, and neurotrauma repair mechanisms, with a strong emphasis on mouse genetics and advanced imaging techniques.

پروفایل رسمی دانشگاه